Serum is generally regarded as an essential component of many eukaryotic cell culture media, despite the fact that serum composition varies greatly and may be the source of a wide range of artefacts. The objective of this study was to assess serum-free growth conditions for the human embryonal carcinoma cell line, NT2/D1. These cells greatly resemble embryonic stem cells. In the presence of retinoic acid (RA), NT2/D1 cells irreversibly differentiate along the neuronal lineage. We have previously shown that the early phases of neural induction of these cells by RA involve the up-regulation of SOX3 gene expression. Our goal was to compare RA-induced differentiation of NT2/D1 cells in serum-containing and serum-free media, by using SOX3 protein levels as a marker of differentiation. We found that NT2/D1 cells can be successfully grown under serum-free conditions, and that the presence or absence of serum does not affect the level of SOX3 protein after a 48-hour RA induction. However, six days of RA treatment resulted in a marked increase in SOX3 protein levels in serum-free media compared to serum-containing media, indicating that serum might have an inhibitory effect on the expression of this neural differentiation marker. This finding is important for both basic and translational studies that hope to exploit cell culture conditions that are free of animal-derived products.
AndrewsP.W. (2002). From teratocarcinomas to embryonic stem cells. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences357, 405–417.
2.
AndrewsP.W., DamjanovI., SimonD., BantingG.S., CarlinC., DracopoliN.C. & FøghJ. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Laboratory Investigation50, 147–162.
3.
AndrewsP.W. (1998). Teratocarcinomas and human embryology: Pluripotent human EC cell lines. Review article. Acta Pathologica, Microbiologica et Immunologica Scandinavica106, 158–167.
4.
AndrewsP.W. (1984). Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Developmental Biology103, 285–293.
5.
KurieJ.M., BrownP., SalkE., ScheinbergD., BirrerM., DeutschP. & DmitrovskyE. (1993). Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation. Differentiation54, 115–122.
6.
SpinellaM.J., FreemantleS.J., SekulaD., ChangJ.H., ChristieA.J. & DmitrovskyE. (1999). Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. Journal of Biological Chemistry274, 22, 013–22, 018.
7.
BurgerH., NooterK., BoersmaA.W., KortlandC.J. & StoterG. (1998). Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. British Journal of Cancer77, 1562–1567.
8.
SpinellaM.J., KerleyJ.S., WhiteK.A. & CurtinJ.C. (2003). Retinoid target gene activation during induced tumor cell differentiation: Human embryonal carcinoma as a model. Journal of Nutrition133, 273S–276S.
9.
RossS.A., McCafferyP.J., DragerU.C. & De LucaL.M. (2000). Retinoids in embryonal development. Physiological Reviews80, 1021–1054.
10.
AltucciL. & GronemeyerH. (2001). The promise of retinoids to fight against cancer. Nature Reviews Cancer1, 181–193.
11.
MadenM. (2002). Retinoid signalling in the development of the central nervous system. Nature Reviews Neuroscience3, 843–853.
12.
WoehrlingE.K., HillE.J., NagelD. & ColemanM.D. (2013). Brain-derived neurotrophic factor as an indicator of chemical neurotoxicity: An animal-free CNS cell culture model. ATLA41, 503–511.
ChenT. & ChenK. (2009). Investigation and application progress of Vero cell serum-free culture. International Journal of Biology1, 7.
15.
Hong-meiP. & Gui-anC. (2006). Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Human Reproduction21, 217–222.
BrunnerD., FrankJ., ApplH., SchöfflH., PfallerW. & GstraunthalerG. (2010). Serum-free cell culture: The serum-free media interactive online database. ALTEX27, 53–62.
18.
van der ValkJ., BrunnerD., De SmetK., Fex SvenningsenA., HoneggerP., KnudsenL.E., LindlT., NorabergJ., PriceA., ScarinoM.L. & GstraunthalerG. (2010). Optimization of chemically defined cell culture media — replacing fetal bovine serum in mammalian in vitro methods. Toxicology in Vitro24, 1053–1063.
19.
RomijnH.J. (1988). Development and advantages of serum-free, chemically defined nutrient media for culturing of nerve tissue. Biology of the Cell63, 263–268.
20.
ChinA.C., PadmanabhanJ., OhS.K. & ChooA.B. (2010). Defined and serum-free media support undifferentiated human embryonic stem cell growth. Stem Cells & Development19, 753–761.
21.
BardyJ., ChenA.K., LimY.M., WuS., WeiS., WeipingH., ChanK., ReuvenyS. & OhS.K. (2013). Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Engineering Part C: Methods19, 166–180.
22.
RizzinoA. & SatoG. (1978). Growth of embryonal carcinoma cells in serum-free medium. Proceedings of the National Academy of Sciences of the USA75, 1844–1848.
23.
EngströmW., ReesA.R. & HeathJ.K. (1985). Proliferation of a human embryonal carcinoma-derived cell line in serum-free medium: Inter-relationship between growth factor requirements and membrane receptor expression. Journal of Cell Science73, 361–373.
LevineJ.M. & FlynnP. (1986). Cell surface changes accompanying the neural differentiation of an embryonal carcinoma cell line. Journal of Neuroscience6, 3374–3384.
26.
XiaC., WangC., ZhangK., QianC. & JingN. (2007). Induction of a high population of neural stem cells with anterior neuroectoderm characters from epiblast-like P19 embryonic carcinoma cells. Differentiation75, 912–927.
27.
PacherníkJ., BryjaV., EsnerM., KubalaL., DvorákP. & HamplA. (2005). Neural differentiation of pluripotent mouse embryonal carcinoma cells by retinoic acid: Inhibitory effect of serum. Physiological Research54, 115–122.
28.
StevanovicM. (2003). Modulation of SOX2 and SOX3 gene expression during differentiation of human neuronal precursor cell line NTERA2. Molecular Biology Reports30, 127–132.
29.
MojsinM., GrujicićN.K., NikcevićG., KrstićA., SavićT. & StevanovićM. (2006). Mapping of the RXRalpha binding elements involved in retinoic acid induced transcriptional activation of the human SOX3 gene. Neuroscience Research56, 409–418.
30.
UchikawaM., KamachiY. & KondohH. (1999). Two distinct subgroups of Group B Sox genes for transcriptional activators and repressors: Their expression during embryonic organogenesis of the chicken. Mechanisms of Development84, 103–120.
31.
BylundM., AnderssonE., NovitchB.G. & MuhrJ. (2003). Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nature Neurosciences6, 1162–1168.
32.
PevnyL. & PlaczekM. (2005). SOX genes and neural progenitor identity. Current Opinion in Neurobiology15, 7–13.
33.
FerriA.L., CavallaroM., BraidaD., Di CristofanoA., CantaA., VezzaniA., OttolenghiS., PandolfiP.P., SalaM., DeBiasiS. & NicolisS.K. (2004). Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development131, 3805–3819.
34.
RizzotiK., BrunelliS., CarmignacD., ThomasP.Q., RobinsonI.C. & Lovell-BadgeR. (2004). SOX3 is required during the formation of the hypothalamo-pituitary axis. Nature Genetics36, 247–255.
35.
EkonomouA., KazanisI., MalasS., WoodH., AlifragisP., DenaxaM., KaragogeosD., ConstantiA., Lovell-BadgeR. & EpiskopouV. (2005). Neuronal migration and ventral subtype identity in the telencephalon depend on SOX1. PLoS Biology3, e186.
36.
BradfordM.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry72, 248–254.
37.
Kovacevic-GrujicicN., MojsinM., KrsticA. & StevanovicM. (2005). Functional characterization of the human SOX3 promoter: Identification of transcription factors implicated in basal promoter activity. Gene344, 287–297.
38.
de WinterJ.C.F. (2013). Using the Student's t-test with extremely small sample sizes. Practical Assessment, Research & Evaluation18.
39.
NikcevićG., SavićT., Kovacević-GrujicićN. & StevanovićM. (2008). Up-regulation of the SOX3 gene expression by retinoic acid: Characterization of the novel promoter-response element and the retinoid receptors involved. Journal of Neurochemistry107, 1206–1215.
40.
KrsticA., MojsinM. & StevanovicM. (2007). Regulation of SOX3 gene expression is driven by multiple NF-Y binding elements. Archives of Biochemistry & Biophysics467, 163–173.
41.
PopovicJ., StanisavljevicD., SchwirtlichM., KlajnA., MarjanovicJ. & StevanovicM. (2014). Expression analysis of SOX14 during retinoic acid induced neural differentiation of embryonal carcinoma cells and assessment of the effect of its ectopic expression on SOXB members in HeLa cells. PLoS One9, e91852.
42.
KondziolkaD., WechslerL., GoldsteinS., MeltzerC., ThulbornK.R., GebelJ., JannettaP., DeCesareS., ElderE.M., McGroganM., ReitmanM.A. & BynumL. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology55, 565–569.
43.
KondziolkaD., SteinbergG.K., WechslerL., MeltzerC.C., ElderE., GebelJ., DecesareS., JovinT., ZafonteR., LebowitzJ., FlickingerJ.C., TongD., MarksM.P., JamiesonC., LuuD., BellStephensT. & TeraokaJ. (2005). Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. Journal of Neurosurgery103, 38–45.
44.
MeltzerC.C., KondziolkaD., VillemagneV.L., WechslerL., GoldsteinS., ThulbornK.R., GebelJ., ElderE.M., DeCesareS. & JacobsA. (2001). Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery49, 586–591.
45.
NelsonP.T., KondziolkaD., WechslerL., GoldsteinS., GebelJ., DeCesareS., ElderE.M., ZhangP.J., JacobsA., McGroganM., LeeV.M. & TrojanowskiJ.Q. (2002). Clonal human (hNT) neuron grafts for stroke therapy: Neuropathology in a patient 27 months after implantation. American Journal of Pathology160, 1201–1206.
46.
DarmonM., BottensteinJ. & SatoG. (1981). Neural differentiation following culture of embryonal carcinoma cells in a serum-free defined medium. Developmental Biology85, 463–473.
47.
HoudekZ., CendelínJ., KuldaV., BabuškaV., VožehF., HatinaJ., KrálíčkováM., ZechN.H., VeseláI., PacherníkJ. & UherP. (2011). Comparison of P19-derived neuroprogenitor and naive cell survival after intracerebellar application into B6CBA mice. Folia Biologica (Praha)57, 162–169.
48.
HoudekZ., CendelínJ., KuldaV., BabuškaV., CedíkováM., KrálíčkováM., PacherníkJ., StefanoG.B. & VožehF. (2012). Intracerebellar application of P19-derived neuroprogenitor and naive stem cells to Lurcher mutant and wild type B6CBA mice. Medical Science Monitor18, BR174–BR180.
49.
LiY., PowellS., BrunetteE., LebkowskiJ. & MandalamR. (2005). Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnology & Bioengineering91, 688–698.
50.
YamasakiS., TaguchiY., ShimamotoA., MukasaH., TaharaH. & OkamotoT. (2014). Generation of human induced pluripotent stem (iPS) cells in serum- and feeder-free defined culture and TGF-β1 regulation of pluripotency. PLoS One9, e87151.
51.
SandhuJ.K., SikorskaM. & WalkerP.R. (2002). Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. Journal of Neuroscience Research68, 604–614.
